This expands the companies’ previously announced partnership to deliver Cogstate’s digital cognitive assessments with Clario’s eCOA platform offering a dramatically streamlined solution for digital and conventional outcomes with an integrated approach to hardware, training and operational support.
It combines Clario’s eCOA Multimedia technology for audio, photo and patient/clinician data capture with Cogstate’s global clinical network and deep therapeutic expertise in neurodegenerative diseases.
CLARIO COLLECTION FULL
The collaboration drives enhanced data quality and signal detection for the full range of conventional cognitive endpoints common in neuroscience studies. PHILADELPHIA, PA – – Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, announced today, on World Clinical Trials Day, an expansion of its partnership with cognitive science company, Cogstate, to jointly provide data quality solutions to support the unique requirements of neuroscience assessments for therapeutic development. Delivers both high data quality benefits and operational ease for patients and clinicians.Combines Clario’s innovative eCOA Multimedia technologies for audio and photo capture with Cogstate’s global clinical network and therapeutic area expertise.Partnership expansion will help optimize neuroscience cognitive assessments in clinical trials to help bring new therapies to market faster.Clario and Cogstate expand partnership to deliver leading data collection and data quality programs for neuroscience clinical trials Collaboration combines Clario’s eCOA innovations with Cogstate’s expertise in neuroscience research to yield highest quality endpoint
0 kommentar(er)
